PURPOSES: To determine whether the deregulation of genes relevant for normal thymus development can contribute to the biology of thymic epithelial tumors (TET). EXPERIMENTAL DESIGN: Using array comparative genomic hybridization, we evaluated the copy number aberrations of genes regulating thymus development. The expression of genes most commonly involved in copy number aberrations was evaluated by immunohistochemistry and correlated with patients' outcome. Correlation between FOXC1 copy number loss and gene expression was determined in a confirmation cohort. Cell lines were used to test the role of FOXC1 in tumors. RESULTS: Among 31 thymus development-related genes, PBX1 copy number gain and FOXC1 copy number loss were presented in 43.0% and 39.5% of the tumors, respectively. Immunohistochemistry on a series of 132 TETs, including those evaluated by comparative genomic hybridization, revealed a correlation between protein expression and copy number status only for FOXC1 but not for PBX1. Patients with FOXC1-negative tumors had a shorter time to progression and a trend for a shorter disease-related survival. The correlation between FOXC1 copy number loss and mRNA expression was confirmed in a separate cohort of 27 TETs. Ectopic FOXC1 expression attenuated anchorage-independent cell growth and cell migration in vitro. CONCLUSION: Our data support a tumor suppressor role of FOXC1 in TETs.
PURPOSES: To determine whether the deregulation of genes relevant for normal thymus development can contribute to the biology of thymic epithelial tumors (TET). EXPERIMENTAL DESIGN: Using array comparative genomic hybridization, we evaluated the copy number aberrations of genes regulating thymus development. The expression of genes most commonly involved in copy number aberrations was evaluated by immunohistochemistry and correlated with patients' outcome. Correlation between FOXC1 copy number loss and gene expression was determined in a confirmation cohort. Cell lines were used to test the role of FOXC1 in tumors. RESULTS: Among 31 thymus development-related genes, PBX1 copy number gain and FOXC1 copy number loss were presented in 43.0% and 39.5% of the tumors, respectively. Immunohistochemistry on a series of 132 TETs, including those evaluated by comparative genomic hybridization, revealed a correlation between protein expression and copy number status only for FOXC1 but not for PBX1. Patients with FOXC1-negative tumors had a shorter time to progression and a trend for a shorter disease-related survival. The correlation between FOXC1 copy number loss and mRNA expression was confirmed in a separate cohort of 27 TETs. Ectopic FOXC1 expression attenuated anchorage-independent cell growth and cell migration in vitro. CONCLUSION: Our data support a tumor suppressor role of FOXC1 in TETs.
Authors: Paolo A Zucali; Iacopo Petrini; Elena Lorenzi; Maria Merino; Liang Cao; Luca Di Tommaso; Hye Seung Lee; Matteo Incarbone; Beatriz A Walter; Matteo Simonelli; Massimo Roncalli; Armando Santoro; Giuseppe Giaccone Journal: Cancer Date: 2010-10-15 Impact factor: 6.860
Authors: Carol S Trempus; Sung-Jen Wei; Margaret M Humble; Hong Dang; Carl D Bortner; Maria I Sifre; Grace E Kissling; Jeffrey A Sunman; Steven K Akiyama; John D Roberts; Charles J Tucker; Kyung-Soo Chun; Raymond W Tennant; Robert Langenbach Journal: Mol Carcinog Date: 2011-03-22 Impact factor: 4.784
Authors: Joseph H Taube; Jason I Herschkowitz; Kakajan Komurov; Alicia Y Zhou; Supriya Gupta; Jing Yang; Kimberly Hartwell; Tamer T Onder; Piyush B Gupta; Kurt W Evans; Brett G Hollier; Prahlad T Ram; Eric S Lander; Jeffrey M Rosen; Robert A Weinberg; Sendurai A Mani Journal: Proc Natl Acad Sci U S A Date: 2010-08-16 Impact factor: 11.205
Authors: Monte M Winslow; Talya L Dayton; Roel G W Verhaak; Caroline Kim-Kiselak; Eric L Snyder; David M Feldser; Diana D Hubbard; Michel J DuPage; Charles A Whittaker; Sebastian Hoersch; Stephanie Yoon; Denise Crowley; Roderick T Bronson; Derek Y Chiang; Matthew Meyerson; Tyler Jacks Journal: Nature Date: 2011-04-06 Impact factor: 49.962
Authors: Alexander Marx; John K C Chan; Jean-Michel Coindre; Frank Detterbeck; Nicolas Girard; Nancy L Harris; Elaine S Jaffe; Michael O Kurrer; Edith M Marom; Andre L Moreira; Kiyoshi Mukai; Attilio Orazi; Philipp Ströbel Journal: J Thorac Oncol Date: 2015-10 Impact factor: 15.609
Authors: Hyun-Sung Lee; Hee-Jin Jang; Rohan Shah; David Yoon; Masatsugu Hamaji; Ori Wald; Ju-Seog Lee; David J Sugarbaker; Bryan M Burt Journal: Clin Cancer Res Date: 2017-04-11 Impact factor: 12.531
Authors: Iacopo Petrini; Paul S Meltzer; In-Kyu Kim; Marco Lucchi; Kang-Seo Park; Gabriella Fontanini; James Gao; Paolo A Zucali; Fiorella Calabrese; Adolfo Favaretto; Federico Rea; Jaime Rodriguez-Canales; Robert L Walker; Marbin Pineda; Yuelin J Zhu; Christopher Lau; Keith J Killian; Sven Bilke; Donna Voeller; Sivanesan Dakshanamurthy; Yisong Wang; Giuseppe Giaccone Journal: Nat Genet Date: 2014-06-29 Impact factor: 38.330